Stories by aaavl2821

Engineering biology, for real?

Radical optimism: considering the future of immunotherapy

Some CAR-T cells live 8+ years in patients

Google has hired Geisinger's David Feinberg to lead its health strategy

Quest Diagnostics to allow patients to order lab testing from home

SEC Edgar full text search

Pharmacogenetics by design (not by accident)

We can now customize cancer cures, tumor by tumor

The Incredible Expanding Universe of Biotech Stocks

UBiome expands into drug research with $83M

Biotech VC deal terms are more friendly than ever

Anti-aging medicine is so hot, even this controversial idea has investors

Virtual compound screening – the state of the art

Our world in data: cancer

Overview of innovations that brought gene therapy to the clinic

At Silicon Valley’s debutante ball for startups, there’s more biology than ever

Researchers Repair a Mutation in Viable Human embryos with new crispr tech

Experienced biotech VCs and entrepreneurs talk about value creation

The mice with human tumours: Growing pains for a popular cancer model

The biggest obstacles to innovation in large companies

6
7
8
9
10
11
12
13